Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

US8653100B2 · kind B2 · utility

Assignees

• Abb Vie Inc. · US
• Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

• Michael Ochse · Wiesbaden, DE
• Udo Lange · Ludwigshafen, DE
• Wilfried Braje · Ludwigshafen, DE
• Berthold Behl · Ludwigshafen, DE
• Wilfried Hornberger · Wiesbaden, DE
• Mario Mezler · Ludwigshafen, DE
• Wilhelm Amberg · Ludwigshafen, DE
• Charles W. Hutchins · Libertyville, US

Key dates

• Filing date: Mar 31, 2009
• Grant date: Feb 18, 2014
• Expiry date: Aug 15, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D513/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to tetrahydroisoquinoline of the formula (I)or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such tetrahydroisoquinolines, and the use of such tetrahydroisoquinolines for therapeutic purposes. The tetrahydroisoquinolines are GlyT1 inhibitors.